18. Spinocerebellar degeneration
59 clinical trials,   78 drugs   (DrugBank: 28 drugs),   44 drug target genes,   59 drug target pathways

Searched query = "Spinocerebellar degeneration", "SCD", "Spinocerebellar ataxia type I", "SCA1", "Spinocerebellar ataxia type II", "SCA2", "Spinocerebellar ataxia type III", "SCA3", "Machado-Joseph disease", "Spinocerebellar ataxia type VI", "SCA6", "Spinocerebellar ataxia type VII", "SCA7", "Spinocerebellar ataxia type X", "SCA10", "Spinocerebellar ataxia type XII", "SCA12", "Dentatorubural pallidoluysian atrophy", "Dentatorubropallidoluysial atrophy", "DRPLA", "Naito-Koyanagi disease", "Friedreich ataxia", "FRDA", "Ataxia with vitamin E deficiency", "AVED", "Early-onset ataxia with ocular motor ataxia and hypoalbuminemia", "EOAH"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00229632
(ClinicalTrials.gov)
September 27, 200529/9/2005Idebenone to Treat Friedreich's AtaxiaA Six Month Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Determine the Safety and Efficacy of Idebenone Administered to Patients With Friedreich's AtaxiaFriedreich AtaxiaDrug: IdebenoneNational Institute of Neurological Disorders and Stroke (NINDS)NULLCompleted9 Years17 YearsAll51Phase 2United States
2NCT00078481
(ClinicalTrials.gov)
February 200427/2/2004Phase 1 Trial of Idebenone to Treat Patients With Friedreich's AtaxiaPhase 1B Clinical Trial to Establish the Safety and Tolerability of a Multiple-Dose Regimen of Idebenone Administered to Patients With Friedreich's AtaxiaFriedreich AtaxiaDrug: IdebenoneNational Institute of Neurological Disorders and Stroke (NINDS)NULLCompletedN/AN/ABoth16Phase 1United States
3NCT00015808
(ClinicalTrials.gov)
May 20016/5/2001Safety Study of Idebenone to Treat Friedreich's AtaxiaPhase I Clinical Trial to Establish the Maximum Tolerated Dose of Idebenone in Children, Adolescents, and Adults With Friedreich's AtaxiaFriedreich AtaxiaDrug: IdebenoneNational Institute of Neurological Disorders and Stroke (NINDS)NULLCompletedN/AN/ABoth100Phase 1United States